BAYER AKTIENGES ADS | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (55)

Latest Posts

About This Stock More About This Stock
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
Article By: ChinaBio® Today
Sunday, February 11, 2024 12:40 PM EDT
I-Mab will become a completely US-based company, divesting itself of I-Mab Biopharma (Hangzhou), an unconsolidated affiliate. I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China for $80 million.
In this article: BAYRY, TRIB, IMAB, IVBXF, ESAIY
Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week
Article By: ChinaBio® Today
Saturday, January 13, 2024 1:20 PM EDT
Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will be acquired by Johnson & Johnson for $2 billion.
In this article: GSK, JNJ, NVS, BAYRY, BNTX, PRAX, AMAM, HLVX Also: TAK
Best 4 Agriculture Companies For Your 2024 Investment Portfolio
Article By: Jacobo Weizenblut
Wednesday, December 27, 2023 9:25 AM EDT
Agriculture is and remains, a crucial sector for sustaining life, offering investors diverse opportunities in this vital industry.
In this article: ICL, ADM, TSN, BAYRY
Earnings Review: Bayer To Make Strategic Changes After Q3 Results
Article By: The Tokenist
Wednesday, November 8, 2023 7:20 AM EDT
The latest financial statements from Bayer Group show a year-over-year decline in several key areas, painting a stark picture of the company’s fiscal health.
In this article: BAYRY
Daily Stock Analysis: Bayer AG - May '23 Update
Article By: Fredrik Arnold
Wednesday, May 17, 2023 6:29 AM EDT
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as over the counter products.
In this article: BAYRY

Latest Tweets for $BAYRY

No tweets yet!